Mandate

Vinge advises Altor in connection with its acquisition of a significant minority stake in Marshall Group AB (publ)

Vinge advises the Altor Funds (“Altor”) in connection with its acquisition of a significant minority stake in Marshall Group AB (publ) (“Marshall”) from Varenne AB, Varenne Invest I AB, Zenith Venture Capital I AB, Zenith Venture Capital III AB as well as a large number of smaller investors.

Marshall is an audio-, tech- and design powerhouse, active in more than 90 markets, with approximately SEK four billion of revenues and employs approximately 800 people across eight locations globally.

Vinge’s team consisted mainly of Christina Kokko, Johanna Wiberg and Viktor Lennartsson (M&A), David Olander (Competition), Victor Ericsson and Emelie Svanberg (Tax).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026